Stocks · Korea
318010
KOSDAQ
Pharmsville
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER9.64x
PBR0.42x
EPS374 KRW
BPS8,596 KRW
ROE4.44%
Dividend yield5.55%
DPS200 KRW
Payout ratio53.48%
Returns and 52-week range
1W+2.71%
1M-2.17%
3M+4.80%
6M+3.00%
1Y-9.99%
YTD+3.00%
52W high4,320원
52W low3,135원
From 52W high-16.55%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 261억 | 41억 | 0원 | 15.6% |
| 2023 | 214억 | 16억 | 33억 | 7.6% |
| 2024 | 167억 | -3억 | 16억 | -1.5% |
| 2025 | 127억 | -7억 | 29억 | -5.3% |
| Quarterly | ||||
| 2024 4Q | 36억 | -2억 | 10억 | -5.1% |
| 2025 1Q | 33억 | 88,540,277원 | 11억 | 2.6% |
| 2025 2Q | 33억 | 88,540,277원 | 11억 | 2.6% |
| 2025 3Q | 34억 | -1억 | 5억 | -3.5% |
| 2025 4Q | 27억 | -7억 | 2억 | -27.2% |
| 2026 1Q | 25억 | -55,278,439원 | 12억 | -2.2% |
Company
Address: 서울특별시 강서구 마곡중앙8로3길 37 -
Peers in the same sector
Recent filings
- 2026-08-20[기재정정]반기보고서 (2026.06)
- 2026-08-20[기재정정]분기보고서 (2026.03)
- 2026-08-13반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.